Vendor, Seattle, WA
G21 Nucleonics Inc.
UEI LAQWW3D7KUK5, CAGE 148H5
1 award and $1,274,900 obligated between September 10, 2026 and September 10, 2026, 100% under full and open competition, against 500.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $1,274,900 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 80NSSC26C0113Definitive Contract, September 10, 2026, Full and Open Competition After Exclusion of Sources, 500 offers | NASA Shared Services CenterNational Aeronautics and Space Administration | SBIR Phase II - IN-SITU Radioisotope Sterilization for Backward and Forward Contamination - Enabling Low-Mass, Low-Complexity Solutions for NAICS 541715, PSC AJ11 | $1,274,900 |
- Places of performance
- Washington
- Product and service codes
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Transactions
- 1 across 1 awards